Day: April 14, 2023

Turin, 14^th April 2023. Iveco Group N.V. (MI: IVG) (the Company or IVG) announces that its shareholders approved all the resolutions proposed by the Board of Directors (the Board) at their Annual General Meeting (AGM) held today in Amsterdam, the Netherlands.

The AGM:

• adopted the 2022 Annual Financial Statements;
• expressed a majority of votes in favour of the Remuneration Report for the Financial Year 2022;
• granted Executive and Non-Executive Directors discharge from liability for the exercise of their duties in the Financial Year 2022;
• reappointed Suzanne Heywood and Gerrit Marx as Executive Directors, and Tufan Erginbilgic, Essimari Kairisto, Linda Knoll, Alessandro Nasi, Olof Persson, Benoît Ribadeau-Dumas and Lorenzo Simonelli as Non-Executive Directors of the Company. Subsequently, the Board confirmed Ms Heywood, Mr Marx and Mr Simonelli as Chairperson, Chief Executive Officer and Senior Non-Executive Director, respectively;
• authorised the Board to repurchase up to 10,000,000 Common Shares with a maximum total allocation of €130,000,000 for a period of 18 months from the date of the AGM.

Details of all matters discussed today at the AGM are available on the Company’s website (www.ivecogroup.com), where the Chairperson’s and the Chief Executive Officer’s presentations, as well as the voting results, will be posted shortly.

Concurrently, the Company published its 2022 Sustainability Report, which is available on the corporate website (www.ivecogroup.com).

This is Iveco Group’s first Sustainability Report as an independent Company. It was written in line with multiple international reporting requirements and sustainability reporting guidelines, and it outlines Iveco Group’s plan to become increasingly sustainable and the Company’s ESG achievements in 2022.

The Company also announces that it launches today an initial tranche (up to € 55,000,000) of its share buyback program with the aim of repurchasing up to 10,000,000 Common Shares for a maximum total allocation of € 130,000,000 for the whole buyback initiative, as outlined above.

The initial tranche of the buyback program will end on 20^th December 2023 (subject to suspension or early termination) and will be carried out pursuant to the terms and conditions of the authorisation granted at the AGM, in compliance with all applicable laws and regulations including the European Commission Regulation (EU) 596/2014 and the Commission Delegated Regulation (EU) 2016/1052. The Company has engaged a primary financial institution as the intermediary to manage the purchase of IVG Common Shares on Euronext Milan and on multilateral trading facilities; this financial institution will make its trading decisions independent of the Company. The repurchased Common Shares will be used to meet the Company’s obligations under its equity incentive plans, as existing from time to time.

Any changes to the information above will be promptly disclosed. The Company will report on the progress of the purchases in accordance with the applicable rules.

As of today, the Company holds in treasury 71,945 Special Voting Shares, and no Common Shares. No IVG shares are held by entities the Company controls.

Iveco Group N.V. (MI: IVG) is the home of unique people and brands that power your business and mission to advance a more sustainable society. The eight brands are each a major force in its specific business: IVECO, a pioneering commercial vehicles brand that designs, manufactures, and markets heavy, medium, and light-duty trucks; FPT Industrial, a global leader in a vast array of advanced powertrain technologies in the agriculture, construction, marine, power generation, and commercial vehicles sectors; IVECO BUS and HEULIEZ, mass-transit and premium bus and coach brands; IDV, for highly-specialised defence and civil protection equipment; ASTRA, a leader in large-scale heavy-duty quarry and construction vehicles; MAGIRUS, the industry-reputed firefighting vehicle and equipment manufacturer; and IVECO CAPITAL, the financing arm which supports them all. Iveco Group employs more than 35,000 people around the world and has 26 manufacturing plants and 29 R&D centres. Further information is available on the Company’s website www.ivecogroup.com

Media Contacts:
Francesco Polsinelli, Mob: +39 335 1776091
Fabio Lepore, Mob: +39 335 7469007
E-mail: mediarelations@ivecogroup.com

Investor Relations:
Federico Donati, Tel: +39 011 0073539
E-mail: investor.relations@ivecogroup.com

Attachment

• 20230414_PR_Iveco_Group_AGM_Results_Launch_Share_Buyback_Program

GlobeNewswire Distribution ID 1000803927

KUALA LUMPUR, Malaysia, April 13, 2023 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, or the “Company”) a multi-disciplinary consulting group with key advisory practices in the areas of business and technology, announced that its ordinary shares have commenced trading on The Nasdaq Capital Market today under the ticker symbol “VCIG.” The shares closed their first day of trading above the offering price at $4.25.

On April 13, 2023, the Company priced its firm commitment underwritten public offering (the “Offering”) of 1,280,000 shares of ordinary shares at a public offering price of $4.00 per share. The gross proceeds to the Company were $5,120,000 before deducting underwriting discounts, commissions and other Offering expenses.

Boustead Securities, LLC and Sutter Securities, Inc. acted as the underwriters for the firm commitment Offering.

A registration statement on Form F-1, as amended (File No. 333-268109), filed by the Company with the Securities and Exchange Commission (the “SEC”), was declared effective on March 30, 2023. The Offering has been made only by means of a prospectus. A copy of the final prospectus related to the Offering may be obtained, when available, from Boustead Securities, LLC, via email: offerings@boustead1828.com, or by calling +1 (949) 502-4408, or by standard mail at Boustead Securities, LLC, Attn: Equity Capital Markets, 6 Venture, Suite 395, Irvine, CA 92618, USA. In addition, a copy of the final prospectus, when available, relating to the Offering may be obtained via the SEC’s website at www.sec.gov.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About VCI Global Limited

VCI Global is a multi-disciplinary consulting group with key advisory practices in the areas of business and technology. The Company provides business and boardroom strategy services, investor relation services, and technology consultancy services. Its clients range from small-medium enterprises and government-linked agencies to publicly traded companies across a broad array of industries. VCI Global operates solely in Malaysia, with clients predominantly from Malaysia, but also serves some clients from China, Singapore, and the US.

For more information on the Company, please log on to https://v-capital.co/.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company’s ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including without limitation, the Company’s ability to achieve profitable operations, customer acceptance of new products, the effects of the spread of Coronavirus (COVID-19) and future measures taken by authorities in the countries wherein the Company has supply chain partners, the demand for the Company’s products and the Company’s customers’ economic condition, the impact of competitive products and pricing, successfully managing and general economic conditions and other risk factors detailed in the Company’s filings with the United States Securities and Exchange Commission. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update the forward-looking statements in this release, except in accordance with applicable law.

CONTACT INFORMATION:

Issued by Imej Jiwa Communications Sdn Bhd and ICR Inc. on behalf of VCI Global Limited
For media queries, please contact:

Imej Jiwa Communications Sdn Bhd
Chris Chuah
Email: chris@imejjiwa.com

ICR Inc.
Investor Relations
Michael Bowen
Vciglobal.ir@icrinc.com

Public Relations
Brad Burgess
Vciglobal.pr@icrinc.com

Boustead Securities, LLC
Underwriter
Dan McClory, Head of Equity Capital Markets
dan@boustead1828.com

GlobeNewswire Distribution ID 8807809

Houston, Texas, April 13, 2023 (GLOBE NEWSWIRE) — You may have heard the motto, “Those who dare to teach must never cease to learn.” This principle strongly applies to two Houston-area educators who, through Centro Semillero at University of St. Thomas-Houston (UST), have confirmed their callings as teachers and fortified their faith. Moreover, they are applying the academic program’s four pillars — kindness, discipline, knowledge, and community — to everything they do.

Angel de Jesus Garcia, Current Master’s Student

One of them is Angel de Jesus Garcia, a college advisor at Houston Independent School District and currently enrolled in Centro Semillero’s Master of Sacred Scriptures Program.

“When my friends told me that St. Thomas was about to launch a master’s degree program in Spanish, I went to orientation and decided to give it try,” Garcia said. “That’s how I became part of the first generation of Spanish-speaking theology students, and I thank God for that decision.”

Garcia made this decision because it perfectly supported both his profession as an educator and his after-work role as a leader at his parish’s youth ministry where he attends pastoral meetings, plans retreats, and creates Christian formation programs.

About Centro Semillero

Centro Semillero was created in 2019 as a graduate studies program in pastoral and biblical studies theology at the UST School of Humanities. Offered online and 100% in Spanish, Centro Semillero offers two postgraduate programs: a Master’s in Pastoral Theology and a Master’s in Sacred Scriptures.

“Centro Semillero,” according to its director Father Dempsey Rosales Acosta, “is inspired by the book of Proverbs 2:2-3 when fulfilling the invitation to incline our hearts to the understanding and study of God to grow in his love. Our center offers the opportunity to fulfill this goal of personal and professional growth by obtaining a postgraduate degree in pastoral or biblical studies at UST from the comfort of your home with our 100% online programs.”

Iris Lai Nayas, MAPT ‘21

For Iris Lai Nayas, a 9th-grade Spanish teacher at Pasadena Independent School District, and a graduate of the Pastoral Theology program in 2021, the concepts she learned have opened a door for dialogue with colleagues from other religions.

Nayas said, “The program has helped me find pastoral strategies for interacting with my colleagues, who are not necessarily Catholic. The strategies enable me to dialogue with all of my colleagues and live experiences of faith without losing the essence of mine.”

Most importantly, the program has made her realize that through her interactions with her students and peers, she can be a testament to God’s presence.

“Today, schools they have taken God out of the classroom but thanks to this program, I understand that God has never been outside, and it is up to me to present him, through values, justice, love, prudence, prayer, and faith,” adds Nayas.

Thanks to her graduate degree, Nayas is also a facilitator in the Small Communities of Salt and Light of Maryknoll Fathers and Brothers.

How to Enroll

Centro Semillero has open enrollment for new students. To learn more about Centro Semillero click here.

Attachments

• Angel de Jesus Garcia
• Iris Lai Nayas, MAPT ’21

Sandra Soliz
University of St. Thomas - Houston
713-906-7912
solizs@stthom.edu

GlobeNewswire Distribution ID 8807777

INSIDE INFORMATION
REGULATED INFORMATION

Nyxoah Raises $3 Million from its At-the-Market Equity Offering 

Mont-Saint-Guibert, Belgium – April 13, 2023, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company raised $3.0 million in gross proceeds pursuant to the Company’s $50 million at-the-market (“ATM”) program established on December 22, 2022 at an issue price equal to the market price on the Nasdaq Global Market at the time of the sale. The proceeds will be used for general corporate purposes.

The ordinary shares described above were sold pursuant to the Company’s shelf registration statement on Form F-3 (File No. 333-268955), previously filed with the Securities and Exchange Commission (“SEC”) on December 22, 2022, which became effective on January 6, 2023, and a prospectus supplement dated January 6, 2023 and the accompanying prospectus the Company filed with the SEC in connection with the offer and sale of the Company’s common stock pursuant to the Controlled Equity Offering^SM Sales Agreement, dated as of December 22, 2022 with Cantor Fitzgerald & Co., as sales agent (prospectus@cantor.com).

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and U.S. commercialization approval.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

FORWARD-LOOKING STATEMENTS

Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company’s or, as appropriate, the Company directors’ or managements’ current expectations regarding the Genio® system; planned and ongoing clinical studies of the Genio® system; the potential advantages of the Genio® system; Nyxoah’s goals with respect to the development, regulatory pathway and potential use of the Genio® system; the utility of clinical data in potentially obtaining FDA approval of the Genio® system; and the Company’s results of operations, financial condition, liquidity, performance, prospects, growth and strategies. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. Additionally, these risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20-F for the year ended December 31, 2022, filed with the Securities and Exchange Commission (“SEC”) on March 22, 2023, and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward-looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person’s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

Contacts:
Nyxoah
David DeMartino, Chief Strategy Officer
david.demartino@nyxoah.com
+1 310 310 1313

Attachment

• ENGLISH_ATM_FINAL

GlobeNewswire Distribution ID 1000803834